| Financial Year |
March 31 2023 |
| Monetary Funds |
901,368,446.83 |
| Held-for-trading Financial Assets |
101,199,082.55 |
| Notes Receivable |
327,690,536.23 |
| Accounts Receivable |
465,222,980.73 |
| Advances to Suppliers |
30,399,780.15 |
| Other Receivables |
7,213,884.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
258,080,918.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,224,890.25 |
| Total Current Assets |
2,098,785,773.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,344,741.27 |
| Investment Properties |
11,733,202.57 |
| Fixed Assetes |
153,190,152.08 |
| Under-construction Projects |
43,755,786.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,741,197.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,021,888.43 |
| Deferred Income Tax Assets |
34,820,787.39 |
| Other Non-Current Assets |
44,523,216.45 |
| Sub-Total of Non-Current Assets |
384,267,412.36 |
| Total Assets |
2,483,053,185.75 |
| Short-Term Loans |
16,300,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
481,300,812.21 |
| Accounts Payable |
393,855,133.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,802,432.80 |
| Taxes Payable |
8,965,059.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,019,326.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
410,293.77 |
| Other Current Liabilities |
20,660,814.36 |
| Sub-Total of Current Liabilities |
1,147,243,213.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,794,506.63 |
| Deferred Income Tax Liabilities |
2,311,632.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
38,046,970.63 |
| Total Liabilities |
1,185,290,183.86 |
| Paid-In Capital(Or Share Stock) |
216,000,000.00 |
| Capital Surplus |
418,983,521.80 |
| Surplus Reserve |
100,589,760.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
510,167,703.98 |
| Minority Stockholder's Interest |
14,196,623.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,283,566,378.62 |
| Owner's Equity（Stockholder's Equity） |
1,297,763,001.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,483,053,185.75 |
